Bacitracin/lidocaine/polymyxin b

The human MATN2-6*His fusion protein from Proteintech is 26 - 351 aa of human MATN2 expressed in E. coli with the expression vector PET30a. This protein has been detected in SDS-page gel. The protein is lyophilized powder.

The human OTC-6*his fusion protein from Proteintech is 35-354aa of human OTC expressed in E. coli with the expression vector PET28a. This protein has been detected in SDS-page gel. The protein is lyophilized powder.

The human OTX2-6*his fusion protein from Proteintech is 1 - 297 aa of human OTX2 expressed in E. coli with the expression vector PET28a. This protein has been detected in SDS-page gel. The protein is lyophilized powder.

The human SCARB2-6*His fusion protein from Proteintech is 249 - 433 aa of human LIMPII expressed in E. coli with the expression vector PET30a. This protein has been detected in SDS-page gel. The protein is lyophilized powder.

The human SHARPIN-6*his fusion protein from Proteintech is 1 - 326 aa of human SHARPIN expressed in E. coli with the expression vector PET28a. This protein has been detected in SDS-page gel. The protein is lyophilized powder.

The human SPANXN4-6*his fusion protein from Proteintech is 22-99aa of human SPANXN4 expressed in E. coli with the expression vector PET28a. This protein has been detected in SDS-page gel. The protein is lyophilized powder.

Antiviral which also inhibits Protein Kinase C and to a lesser extent Casein Kinase II and MAP Kinase.

Antiviral which also inhibits Protein Kinase C and to a lesser extent Casein Kinase II and MAP Kinase.

Immunotag™ Olfactory receptor 6C70 Polyclonal Antibody-Biotin*

Immunotag™ Olfactory receptor 6C70 Polyclonal Antibody-Biotin*

InformationIMR-1 IMR-1 is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 26 μM.TargetsNotch (Cell-free assay) 26 μMCell Research(from reference)Cell lines：OE33 and 786-0 cells Concentrations：5, 10, 15, 25 μM.

InformationIMR-1A IMR-1A, an acid metabolite of IMR-1, is a potent inhibitor of Notch with IC50 of 0.5 μM and Kd of 2.9 μM. IMR-1A exhibits anti-tumor activity.TargetsNotch (Cell-free assay): Notch (Cell-free assay) 0.5 μM: 2.9 μM(Kd).